TECX Q4 2020 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$309,000

Operating Income

-$28M

Net Income

-$28M

EPS (Diluted)

$-8.76

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$271M

Total Liabilities

$17M

Stockholders' Equity

$254M

Cash & Equivalents

$260M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$309,000	-$245,000	-26.1%
Operating Income	-$28M	-$23M	-19.8%
Net Income	-$28M	-$23M	-24.1%